Publikationen 2013

  1. Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA. „SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR).“ J Cardiovasc Comput Tomogr. 2012 Nov-Dec;6(6):366-80
  2. Al-Mallah MH, Qureshi W, Lin FY, Achenbach S, Berman DS, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Chinnaiyan K, Chow BJ, Cheng VY, Delago A, Gomez M, Hadamitzky M, Hausleiter J, Kaufmann PA, Leipsic J, Maffei E, Raff G, Shaw LJ, Villines TC, Cury RC, Feuchtner G, Plank F, Kim YJ, Dunning AM, Min JK. „Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry.“ Eur Heart J Cardiovasc Imaging. 2013 Aug 21. [Epub ahead of print].
  3. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013 Mar 18;2(2):e000102. doi: 10.1161/JAHA.112.000102.
  4. Ammar S, Hessling G, Reents T, Paulik M, Fichtner S, Schön P, Dillier R, Kathan S, Jilek C, Kolb C, Haller B, Deisenhofer I. Importance of sinus rhythm as endpoint of persistent atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2013 Apr;24(4):388-95.
  5. Aradi D, Storey RF, Komócsi A, Trenk D, Gulba D, Kiss RG, Husted S, Bonello L, Sibbing D, Collet JP, Huber K; on behalf of the Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J. 2013 Sep 25. [Epub ahead of print]
  6. Aradi D, Sibbing D, Bonello L. Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatment. Int J Cardiol. 2013 Sep 1;167(5):1794-7. doi: 10.1016/j.ijcard.2012.12.026. Epub 2013 Jan 3.
  7. Becker A, Becker C. CT imaging of myocardial perfusion: possibilities and perspectives. J Nucl Cardiol. 2013 Apr;20(2):289-96. doi: 10.1007/s12350-013-9681-7. Review. IF 2.85.
  8. Beckmann BM, Wilde AA, Kääb S. Clinical utility gene card for: long-QT syndrome (types 1-13). Eur J Hum Genet. 2013 Oct;21(10). doi: 10.1038/ejhg.2013.28. Epub 2013 Mar 20.  IF 4.32.
  9. Behr ER, Ritchie MD, Tanaka T, Kääb S, Crawford DC, Nicoletti P, Floratos A, Sinner MF, Kannankeril PJ, Wilde AA, Bezzina CR, Schulze-Bahr E, Zumhagen S, Guicheney P, Bishopric NH, Marshall V, Shakir S, Dalageorgou C, Bevan S, Jamshidi Y, Bastiaenen R, Myerburg RJ, Schott JJ, Camm AJ, Steinbeck G, Norris K, Altman RB, Tatonetti NP, Jeffery S, Kubo M, Nakamura Y, Shen Y, George AL Jr, Roden DM. Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One. 2013 Nov 6;8(11):e78511. doi: 10.1371/journal.pone.0078511.
  10. Bernlochner I, Mayer K, Morath T, Orban M, Schulz S, Schömig A, Braun S, Kastrati A, Sibbing D. Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting.Thromb Haemost. 2013 Mar 5;109(3):517-24. doi: 10.1160/TH12-08-0552. Epub 2013 Jan 17. IF: 6.08.
  11. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Borggrefe M, Schimpf R, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Olesen MS, Kääb S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R, Boukens BJ, Bézieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, Le Marec H, Wilde AA, Probst V, Schott JJ, Dina C, Redon R. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet. 2013 Sep;45(9):1044-9. doi: 10.1038/ng.2712. Epub 2013 Jul 21. Erratum in: Nat Genet. 2013 Nov;45(11):1409. Borggrefe, Martin [added]; Schimpf, Rainer [added].
  12. Bischoff B, Hausleiter J. [Rational CT imaging in cardiology]. Internist (Berl). 2013 Jul;54(7):810-7. IF 0,33.
  13. Boekstegers P*, Hausleiter J*, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N. Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol. 2013 Sep 11. IF 3,67.
  14. Bongiorni MG, Proclemer A, Dobreanu D, Marinskis G, Pison L, Blomstrom-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace. 2013 Nov;15(11):1664-8.
  15. Brandt M, Schönfelder T, Schwenk M, Becker C, Jäckel S, Reinhardt C, Stark K, Massberg S, Münzel T, von Brühl ML, Wenzel P. Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches. Clin Hemorheol Microcirc. 2013 Feb 12. [Epub ahead of print]
  16. Braun D*, Orban M*, Michalk F, Barthel P, Hoppe K, Sonne C, Lesevic H, Pache J, Mehilli J, Kastrati A, Hausleiter J, Massberg S. Three-dimensional transoesophageal echocardiography for the assessment of clip attachment to the leaflets in percutaneous edge-to-edge repair of the mitral valve. EuroIntervention. 2013 Apr 22;8(12):1379-87. IF 3.17.
  17. Braun D, Orban M, Tittus J, Näbauer M, Hagl C, Massberg S, Hausleiter J.
    Interventional Mitral valve repair with the MitraClip® procedure. Patient selection criteria.
    Herz. 2013 Aug;38(5):467-73. IF 0,79.
  18. Brunner S*, Theiss HD*, Leiss M, Grabmaier U, Grabmeier J, Huber B, Vallaster M, Clevert DA, Sauter M, Kandolf R, Rimmbach C, David R, Klingel K, Franz WM. Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy. Basic Res Cardiol 2013 Nov;108(6):388. IF 5.90.
  19. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A; ISAR-DESIRE 3 investigators. „Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial.“ Lancet. 2013 Feb 9;381(9865):461-7.
  20. Byrne RA, Cassese S, Windisch T, King LA, Joner M, Tada T, Mehilli J, Pache J, Kastrati A. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: Insights from the isar-desire and isar-desire 2 trials. EuroIntervention. 2013;9:797-802
  21. Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, Papagiannis J, Feldkamp MD, Rathi SG, Kunic JD, Pedrazzini M, Wieland T, Lichtner P, Beckmann BM, Clark T, Shaffer C, Benson DW, Kääb S, Meitinger T, Strom TM, Chazin WJ, Schwartz PJ, George AL Jr. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013 Mar 5;127(9):1009-17. doi: 10.1161/CIRCULATIONAHA.112.001216. Epub 2013 Feb 6.
  22. Dawson K*, Wakili R*, Ordög B, Clauss S, Chen Y, Iwasaki Y, Voigt N, Qi XY, Sinner MF, Dobrev D, Kääb S, Nattel S. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation. 2013 Apr 9;127(14):1466-75, 1475e1-28. doi: 10.1161/CIRCULATIONAHA.112.001207. IF 15,2.
  23. den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, Nolte IM, Segrè AV, Holm H, Handsaker RE, Westra HJ, Johnson T, Isaacs A, Yang J, Lundby A, Zhao JH, Kim YJ, Go MJ, Almgren P, Bochud M, Boucher G, Cornelis MC, Gudbjartsson D, Hadley D, van der Harst P, Hayward C, den Heijer M, Igl W, Jackson AU, Kutalik Z, Luan J, Kemp JP, Kristiansson K, Ladenvall C, Lorentzon M, Montasser ME, Njajou OT, O'Reilly PF, Padmanabhan S, St Pourcain B, Rankinen T, Salo P, Tanaka T, Timpson NJ, Vitart V, Waite L, Wheeler W, Zhang W, Draisma HH, Feitosa MF, Kerr KF, Lind PA, Mihailov E, Onland-Moret NC, Song C, Weedon MN, Xie W, Yengo L, Absher D, Albert CM, Alonso A, Arking DE, de Bakker PI, Balkau B, Barlassina C, Benaglio P, Bis JC, Bouatia-Naji N, Brage S, Chanock SJ, Chines PS, Chung M, Darbar D, Dina C, Dörr M, Elliott P, Felix SB, Fischer K, Fuchsberger C, de Geus EJ, Goyette P, Gudnason V, Harris TB, Hartikainen AL, Havulinna AS, Heckbert SR, Hicks AA, Hofman A, Holewijn S, Hoogstra-Berends F, Hottenga JJ, Jensen MK, Johansson A, Junttila J, Kääb S, Kanon B, Ketkar S, Khaw KT, Knowles JW, Kooner AS, Kors JA, Kumari M, Milani L, Laiho P, Lakatta EG, Langenberg C, Leusink M, Liu Y, Luben RN, Lunetta KL, Lynch SN, Markus MR, Marques-Vidal P, Mateo Leach I, McArdle WL, McCarroll SA, Medland SE, Miller KA, Montgomery GW, Morrison AC, Müller-Nurasyid M, Navarro P, Nelis M, O'Connell JR, O'Donnell CJ, Ong KK, Newman AB, Peters A, Polasek O, Pouta A, Pramstaller PP, Psaty BM, Rao DC, Ring SM, Rossin EJ, Rudan D, Sanna S, Scott RA, Sehmi JS, Sharp S, Shin JT, Singleton AB, Smith AV, Soranzo N, Spector TD, Stewart C, Stringham HM, Tarasov KV, Uitterlinden AG, Vandenput L, Hwang SJ, Whitfield JB, Wijmenga C, Wild SH, Willemsen G, Wilson JF, Witteman JC, Wong A, Wong Q, Jamshidi Y, Zitting P, Boer JM, Boomsma DI, Borecki IB, van Duijn CM, Ekelund U, Forouhi NG, Froguel P, Hingorani A, Ingelsson E, Kivimaki M, Kronmal RA, Kuh D, Lind L, Martin NG, Oostra BA, Pedersen NL, Quertermous T, Rotter JI, van der Schouw YT, Verschuren WM, Walker M, Albanes D, Arnar DO, Assimes TL, Bandinelli S, Boehnke M, de Boer RA, Bouchard C, Caulfield WL, Chambers JC, Curhan G, Cusi D, Eriksson J, Ferrucci L, van Gilst WH, Glorioso N, de Graaf J, Groop L, Gyllensten U, Hsueh WC, Hu FB, Huikuri HV, Hunter DJ, Iribarren C, Isomaa B, Jarvelin MR, Jula A, Kähönen M, Kiemeney LA, van der Klauw MM, Kooner JS, Kraft P, Iacoviello L, Lehtimäki T, Lokki ML, Mitchell BD, Navis G, Nieminen MS, Ohlsson C, Poulter NR, Qi L, Raitakari OT, Rimm EB, Rioux JD, Rizzi F, Rudan I, Salomaa V, Sever PS, Shields DC, Shuldiner AR, Sinisalo J, Stanton AV, Stolk RP, Strachan DP, Tardif JC, Thorsteinsdottir U, Tuomilehto J, van Veldhuisen DJ, Virtamo J, Viikari J, Vollenweider P, Waeber G, Widen E, Cho YS, Olsen JV, Visscher PM, Willer C, Franke L; Global BPgen Consortium; CARDIoGRAM Consortium, Erdmann J, Thompson JR; PR GWAS Consortium, Pfeufer A; QRS GWAS Consortium, Sotoodehnia N; QT-IGC Consortium, Newton-Cheh C; CHARGE-AF Consortium, Ellinor PT, Stricker BH, Metspalu A, Perola M, Beckmann JS, Smith GD, Stefansson K, Wareham NJ, Munroe PB, Sibon OC, Milan DJ, Snieder H, Samani NJ, Loos RJ. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet. 2013 Jun;45(6):621-31. doi: 10.1038/ng.2610. Epub 2013 Apr 14.
  24. Diemert P*, Lange P*, Greif M*, Seiffert M, Conradi L, Massberg S, Blankenberg S, Reichenspurner H, Hagl C, Schmitz C, Schröfel H, Treede H, Schymik G, Kupatt C.  Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol. 2013 Nov 20. [Epub ahead of print]. IF 3,67.
  25. Di Q, Trenkwalder T, Lee S, Chillo O, Deindl D, Kupatt C, Hinkel R. Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia, PlosOne 2013; Apr. 16, e1831. IF 4.1.
  26. Dwivedi G, Cocker M, Yam Y, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan KM, Delago A, Dunning AM, Hadamitzky M, Hausleiter J, Kaufmann PA, LaBounty TM, Lin F, Maffei E, Raff GL, Shaw LJ, Villines TC, Min JK, Chow BJ; CONFIRM Investigators. „Predictive value of cardiac computed tomography and the impact of renal function on all cause mortality (from Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes).“ Am J Cardiol. 2013 Jun 1;111(11):1563-9.
  27. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013 Jan;13(1):34-45. doi: 10.1038/nri3345. Epub 2012 Dec 7. Review. IF 33.13.
  28. Fenske S, Krause SC, Hassan SI, Becirovic E, Auer F, Bernard R, Kupatt C, Lange P, Ziegler T, Wotjak CT, Zhang H, Hammelmann V, Paparizos C, Biel M, Wahl-Schott CA. Sick Sinus Syndrome in HCN1-Deficient Mice. Circulation 2013 (epub ahead of print).
  29. Fichtner S, Kääb S. [Ventricular tachycardia : Treatment and prognostic significance]. Herzschrittmacherther Elektrophysiol. 2013 Dec;24(4):217-22
  30. Fichtner S, Hessling G, Ammar S, Reents T, Estner HL, Jilek C, Kathan S, Büchner M, Dillier R, Deisenhofer I. A prospective randomized study comparing isolation of the arrhythmogenic vein versus all veins in paroxysmal atrial fibrillation. Clin Cardiol. 2013 Jul;36(7):422-6. doi: 10.1002/clc.22132. Epub 2013 May 13. IF 1.83.
  31. Franks Z, Campbell RA, Vieira de Abreu A, Holloway JT, Marvin JE, Kraemer BF, Zimmerman GA, Weyrich AS, Rondina MT: Methicillin-resistant Staphylococcus aureus - induced thrombo-inflammatory response is reduced with timely antibiotic administration. Thromb Haemost 2013, 109(4).
  32. Grabmaier U, Brenner C, Methe H, Kaczmarek I, Schramm R, Klingel K, Hagl C, Franz WM. An alternative immunosuppressive regimen to prolong transplant free survival in a patient with giant cell myocarditis. Int J Cardiol. 2013 Sep 20;168(1):e27-8. doi: 10.1016/j.ijcard.2013.05.078. Epub 2013 Jun 2. IF 5.51.
  33. Grabmaier U, Theiss HD, Franz WM, Hagl C. ECMO therapy after thrombotic left main occlusion bridges prolonged cardiac arrest.Resuscitation. 2013 Jan 26. doi:pii: S0300-9572(13)00047-6. 10.1016/j.resuscitation. 2013.01.016. [Epub ahead of print]. IF 4.1.
  34. Greif M, von Ziegler F, Bamberg F, Tittus J, Schwarz F, D'Anastasi M, Marcus RP, Schenzle J, Becker C, Nikolaou K, Becker A. CT stress perfusion imaging for detection of haemodynamically relevant coronary stenosis as defined by FFR. Heart. 2013. IF 5,01.
  35. Greif M, von Ziegler F, Wakili R, Tittus J, Becker C, Helbig S, Laubender RP, Schwarz W, D'Anastasi M, Schenzle J, Leber AW, Becker A. Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. Clin Res Cardiol. 2013 Aug;102(8):555-62. doi: 10.1007/s00392-013-0566-1. Epub 2013 Apr 13. IF 3.67.
  36. Greif M, Schramm R, Steinbeck G, Hagl C, Schmitz C, Kupatt C. Transfemoral access for valve in valve implantation of an Edwards Sapien XT valve in a stenotic tricuspid bioprosthesis under fluoroscopic guidance. Can J Cardiol. 2013 Aug;29(8):1014.e3-4. doi: 10.1016/j.cjca.2012.11.027. Epub 2013 Feb 11. IF 3,12.
  37. Greif M, Lange P, Mair H, Becker C, Schmitz C, Steinbeck G, Kupatt C., Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. Clin Res Cardiol  2012; 101:993-1001. IF3.0.
  38. Gross L, Massberg S, Sibbing D. [Cardiological diseases]. Internist (Berl). 2013 Oct;54(10):1171-84. doi: 10.1007/s00108-013-3294-8. German.  IF 0.33.
  39. Gutierrez-Chico JL, Mehilli J. Gender differences in cardiovascular therapy: Focus on antithrombotic therapy and percutaneous coronary intervention. Drugs. 2013;73:1921-1933. IF 4.63.
  40. Gutierrez-Chico JL, Jochheim D, Mehilli J. Biodegradable-polymer-based drug-eluting stent for left main coronary artery disease. Minerva Cardioangiol. 2013;61:563-574.
  41. Hadamitzky M, Achenbach S, Al-Mallah M, Berman D, Budoff M, Cademartiri F, Callister T, Chang HJ, Cheng V, Chinnaiyan K, Chow BJ, Cury R, Delago A, Dunning A, Feuchtner G, Gomez M, Kaufmann P, Kim YJ, Leipsic J, Lin FY, Maffei E, Min JK, Raff G, Shaw LJ, Villines TC, Hausleiter J; CONFIRM Investigators. Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry). J Am Coll Cardiol. 2013 Jul 30;62(5):468-76. IF 14,09.
  42. Hadamitzky M, Täubert S, Deseive S, Byrne RA, Martinoff S, Schömig A, Hausleiter J. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease.“ Eur Heart J. 2013 Sep 24. IF 5,25.
  43. Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Kastrati A, Martinoff S, Schömig A, Ibrahim T. „The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT.“ JACC Cardiovasc Imaging. 2013 Mar;6(3):358-69.
  44. Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Byrne RA, Mehilli J, Kastrati A, Schömig A, Martinoff S, Ibrahim T. „Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi “Eur Heart J Cardiovasc Imaging. 2013 Nov 14.
  45. Hinkel R, Penzkofer D, Zühlke S, Fischer A, Husada W, Xu QF, Baloch E, van Rooij E, Zeiher AM, Kupatt C+, Dimmeler S+, Inhibition of MicroRNA-92a Protects Against Ischemia-Reperfusion Injury in a Large Animal Model, Circulation 2013 (epub ahead of print). IF 15.2.
  46. Hinkel R, Lebherz C, Fydanaki M, Wuchrer A, El-Aouni C, Thormann M, Thein E,  Kupatt C,  Boekstegers P, Angiogenetic potential of Ad Hif 1-alpha/VP 16 after regional application in a preclinical pig model of chronic ischemia, Curr Vasc Pharmacol 2013; 11: 29-37. IF 2,9.
  47. Huber BC, Ransohoff JD, Ransohoff KJ, Riegler J, Ebert A, Kodo K, Gong Y, Sanchez-Freire V, Dey D, Kooreman NG, Diecke S, Zhang WY, Odegaard J, Hu S, Gold JD, Robbins RC, Wu JC. Costimulation-Adhesion Blockade is Superior to Cyclosporine A and Prednisone Immunosuppressive Therapy for Preventing Rejection of Differentiated Human Embryonic Stem Cells Following Transplantation. Stem Cells. 2013 Nov;31(11):2354-6. IF 7,7.
  48. Hulten E, Villines TC, Cheezum MK, Berman DS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Cury RC, Delago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Karlsberg RP, Kim YJ, Leipsic J, Lin FY, Maffei E, Plank F, Raff GL, Labounty TM, Shaw LJ, Min JK; CONFIRM Investigators. „Usefulness of coronary computed tomography angiography to predict mortality and myocardial infarction among Caucasian, African and East Asian ethnicities (from the CONFIRM [Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter] Registry).“ Am J Cardiol. 2013 Feb 15;111(4):479-85.
  49. Jilek C, Lennerz C, Stracke B, Badran H, Semmler V, Reents T, Ammar S, Fichtner S, Haller B, Hessling G, Deisenhofer I, Kolb C. Forces on cardiac implantable electronic devices during remote magnetic navigation. Clin Res Cardiol. 2013 Mar;102(3):185-92
  50. Jung PH, Mueller M, Schuhmann C, Eickhoff M, Schneider P, Seemueller G, Dutton R, Rieber J, Kääb S, Sohn HY. Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events. Cardiovasc Ultrasound. 2013 Jan 7;11(1):1. doi: 10.1186/1476-7120-11-1.
  51. King L, Byrne RA, Mehilli J, Schomig A, Kastrati A, Pache J. Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: Final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (isar-test) trial. Catheter Cardiovasc Interv. 2013;81:E23-28.
  52. Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A, Bailleul C, Bax J, Benninger G, Blomstrom-Lundqvist C, Boersma L, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Casadei B, Clemens A, Crijns H, Derwand R, Dobrev D, Ezekowitz M, Fetsch T, Gerth A, Gillis A, Gulizia M, Hack G, Haegeli L, Hatem S, Georg Häusler K, Heidbüchel H, Hernandez-Brichis J, Jais P, Kappenberger L, Kautzner J, Kim S, Kuck KH, Lane D, Leute A, Lewalter T, Meyer R, Mont L, Moses G, Mueller M, Münzel F, Näbauer M, Nielsen JC, Oeff M, Oto A, Pieske B, Pisters R, Potpara T, Rasmussen L, Ravens U, Reiffel J, Richard-Lordereau I, Schäfer H, Schotten U, Stegink W, Stein K, Steinbeck G, Szumowski L, Tavazzi L, Themistoclakis S, Thomitzek K, Van Gelder IC, von Stritzky B, Vincent A, Werring D, Willems S, Lip GY, Camm AJ. Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2013 (11):1540-56.Epub 2013 Aug 27.
  53. Kraemer BF, Weyrich AS, Lindemann S: Protein degradation systems in platelets. Thromb Haemost 2013, 110(5). IF 6.08.
  54. Kraemer BF, Weyrich AS: Polyubiquinated protein depots in platelets and megakaryocytes from patients with ANKRD26-RT. Thromb Haemost 2013, 109(2). IF 6.08.
  55. Kucher N, Boekstegers P, Müller O, Kupatt C, Beyer-Westendorf J, Heitzer T, Tebbe U, Horstkotte J, Müller R, Blessing E, Greif M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Härtel D, Grünwald H, Empen K, Baumgartner I. Randomized Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism. Circulation. 2013 Nov 13. [Epub ahead of print].
  56. Kufner S, Byrne RA, Mehilli J, Massberg S, Birkmeier KA, Schulz S, Pache J, Schömig A, Kastrati A. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: A randomized comparison in setting of ISAR-TEST-4 trial. Catheter Cardiovasc Interv. 2013 Jun 11. doi: 10.1002/ccd.24741. [Epub ahead of print]
  57. Labounty TM, Gomez MJ, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan KM, Chow B, Cury R, Delago A, Dunning A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann P, Kim YJ, Leipsic J, Lin FY, Maffei E, Raff G, Shaw LJ, Villines TC, Min JK. Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13,874 patients. Eur Heart J Cardiovasc Imaging. 2013 May;14(5):456-63.
  58. Langhans B, Ibrahim T, Hausleiter J, Sonne C, Martinoff S, Schömig A, Hadamitzky M. „Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction.“ Int J Cardiovasc Imaging. 2013 Mar;29(3):643-50.
  59. Lehner S, Todica A, Brunner S, Uebleis C, Wang H, Wängler C, Herbach N, Herrler T, Böning G, Laubender RP, Cumming P, Schirrmacher R, Franz WM, Hacker M. Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in mice. Mol Imaging 2012 Nov-Dec; 11(6):461-70.
  60. Lehner S, Uebleis C, Schüßler F, Haug A, Kääb S, Bartenstein P, Van Kriekinge SD, Germano G, Estner H, Hacker M. The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1876-83. doi: 10.1007/s00259-013-2516-6. Epub 2013 Aug 1.
  61. Leibundgut G, Pache J, Schulz S, Berger PB, Ferenc M, Gick M, Mehilli J, Kastrati A, Neumann FJ. Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction. J Interv Cardiol. 2013;26:623-629
  62. Leierseder S, Petzold T, Zhang L, Loyer X, Massberg S, Engelhardt S. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost. 2013 Nov 27;110(6):1207-14. doi: 10.1160/TH13-07-0623. Epub 2013 Sep 26.
  63. Leipsic J, Taylor CM, Grunau G, Heilbron BG, Mancini GB, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Cury R, Feuchtner G, Kim YJ, Kaufmann PA, Lin FY, Maffei E, Raff G, Shaw LJ, Villines TC, Min JK. „Cardiovascular risk among stable individuals suspected of having coronary artery disease with no modifiable risk factors: results from an international multicenter study of 5262 patients.“ Radiology. 2013 Jun;267(3):718-26.
  64. Lerchenberger M, Uhl B, Stark K, Zuchtriegel G, Eckart A, Miller M, Puhr-Westerheide D, Praetner M, Rehberg M, Khandoga AG, Lauber K, Massberg S, Krombach F, Reichel CA. Matrix metalloproteinases modulate ameboid-like migration of neutrophils through inflamed interstitial tissue. Blood. 2013 Aug 1;122(5):770-80. doi: 10.1182/blood-2012-12-472944. Epub 2013 Jun 11.
  65. Lin H, Sinner MF, Brody JA, Arking DE, Lunetta KL, Rienstra M, Lubitz SA, Magnani JW, Sotoodehnia N, McKnight B, McManus DD, Boerwinkle E, Psaty BM, Rotter JI, Bis JC, Gibbs RA, Muzny D, Kovar CL, Morrison AC, Gupta M, Folsom AR, Kääb S, Heckbert SR, Alonso A, Ellinor PT, Benjamin EJ; on behalf of the CHARGE Atrial Fibrillation Working Group. Targeted sequencing in candidate genes for atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study. Heart Rhythm. 2013 Nov 14. pii: S1547-5271(13)01316-7. doi: 10.1016/j.hrthm.2013.11.012. [Epub ahead of print]
  66. Loesch AM, Becker A, Noachtar S. Syncope: there is more than haemodynamic failure. BMJ Case Rep. 2013 Aug 9;2013. doi:pii: bcr2013010347. 10.1136/bcr-2013-010347.
  67. Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W. „Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.“ J Am Coll Cardiol. 2013 Sep 17;62(12):1052-61.
  68. Malle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, Massberg S, Jehle J, Guagliumi G, Kastrati A, Virmani R, Byrne RA, Joner M. Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1376-83. doi: 10.1161/ATVBAHA.113.301227. Epub 2013 Mar 28.
  69. Meder B, Rühle F, Weis T, Homuth G, Keller A, Franke J, Peil B, Lorenzo Bermejo J, Frese K, Huge A, Witten A, Vogel B, Haas J, Völker U, Ernst F, Teumer A, Ehlermann P, Zugck C, Friedrichs F, Kroemer H, Dörr M, Hoffmann W, Maisch B, Pankuweit S, Ruppert V, Scheffold T, Kühl U, Schultheiss HP, Kreutz R, Ertl G, Angermann C, Charron P, Villard E, Gary F, Isnard R, Komajda M, Lutz M, Meitinger T, Sinner MF, Wichmann HE, Krawczak M, Ivandic B, Weichenhan D, Gelbrich G, El-Mokhtari NE, Schreiber S, Felix SB, Hasenfuß G, Pfeufer A, Hübner N, Kääb S, Arbustini E, Rottbauer W, Frey N, Stoll M, Katus HA. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J. 2013 Jul 12. [Epub ahead of print]
  70. Mehilli J, Neumann FJ, Ndrepepa G, King L, Schulz S, Maimer Rodrigues da Cunha F, Jochheim D, Byrne RA, Hausleiter J, Ott I, Massberg S, Kastrati A, Pache J. „Sex-related effectiveness of bivalirudin versus abciximab and heparin in non-ST-segment elevation myocardial infarction.“ Am Heart J. 2013 Apr;165(4):537-43. IF 4.50.
  71. Mehilli J, Richardt G, Valgimigli M, Schulz S, Singh A, Abdel-Wahab M, Tiroch K, Pache J, Hausleiter J, Byrne RA, Ott I, Ibrahim T, Fusaro M, Seyfarth M, Laugwitz KL, Massberg S, Kastrati A. „Zotarolimus- versus Everolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease.“ J Am Coll Cardiol. 2013 Aug 8. IF 14,09.
  72. Mehilli J. Degradable polymer drug-eluting stents: A durable benefit? Lancet. 2013;381:607-60975-2082. IF 39.06.
  73. Meinel FG, Graef A, Bamberg F, Thieme SF, Schwarz F, Sommer WH, Neurohr C, Kupatt C, Reiser MF, Johnson TR. Effectiveness of automated quantification of pulmonary perfused blood volume using dual-energy CTPA fort he severity assessment of acute pulmonary embolism. Invest Radiol 2013; 48: 563-569.
  74. Min JK, Berman DS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan K, Chow BJ, Cury R, Delago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann P, Karlsberg RP, Kim YJ, Leipsic J, Lin FY, Maffei E, Plank F, Raff G, Villines T, Labounty TM, Shaw LJ. „All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry).“ Eur Heart J. 2012 Dec;33(24):3088-97.
  75. Nabauer M. Echokardiographie als Primärdiagnostik für Erkrankungen der Herzklappen Radiologe 2013 (53):857-63. IF 0.47.
  76. Nakazato R, Gransar H, Berman DS, Cheng VY, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines TC, Dunning A, Cury RC, Feuchtner G, Kim YJ, Leipsic J, Min JK. „Relationship of low- and high-density lipoproteins to coronary artery plaque composition by CT angiography.“ J Cardiovasc Comput Tomogr. 2013 Mar-Apr;7(2):83-90.
  77. Neuberger HR, Tilz RR, Bonnemeier H, Deneke T, Estner HL, Kriatselis C, Kuniss M, Luik A, Sommer P, Steven D, von Bary C, Voss F, Eckardt L. A survey of German centres performing invasive electrophysiology: structure, procedures, and training positions. Europace. 2013 Dec;15(12):1741-6. doi: 10.1093/europace/eut149. Epub 2013 Jun 4.
  78. Orban M*, Braun D*, Sonne C, Orban M, Thaler R, Grebmer C, Lesevic H, Schömig A, Mehilli J, Massberg S, Hausleiter J. Dangerous liaison: successful percutaneous edge-to-edge mitral valve repair in patients with end-stage systolic heart failure can cause left ventricular thrombus formation.
    EuroIntervention. 2013 Oct 30. pii: 20130326-01. [Epub ahead of print]. IF 3,17.
  79. Orban M, Sibbing D. Platelet function testing in patients with acute coronary syndrome. J Cardiovasc Transl Res. 2013 Jun;6(3):371-7. doi: 10.1007/s12265-013-9450-7. Epub 2013 Feb 9. IF: 3.00.
  80. Orban M, Sinnecker D, Mair H, Nabauer M, Kupatt C, Schmitz C, Massberg S, Laugwitz KL, Barthel P. Transcatheter aortic-valve endocarditis confirmed by transesophageal echocardiography. Circulation 2013; 127:e265-6. IF 15,2. Case Report.
  81. Otaki Y, Gransar H, Berman DS, Cheng VY, Dey D, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines TC, Dunning A, Min JK. „Impact of family history of coronary artery disease in young individuals (from the CONFIRM registry).“ Am J Cardiol. 2013 Apr 15;111(8):1081-6.
  82. Petzold T, Ruppert R, Pandey D, Barocke V, Meyer H, Lorenz M, Zhang L, Siess W, Massberg S, Moser M. β1 integrin-mediated signals are required for platelet granule secretion and hemostasis in mouse. Blood. 2013 Oct 10;122(15):2723-31. doi: 10.1182/blood-2013-06-508721. Epub 2013 Sep 4. IF 9,06.
  83. Piotrowski K, Becker M, Zugwurst J, Biller-Friedmann I, Spoettl G, Greif M, Leber AW, Becker A, Laubender RP, Lebherz C, Goeke B, Marx N, Parhofer KG, Lehrke M. Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovasc Diabetol. 2013 Aug 16;12(1):117. doi: 10.1186/1475-2840-12-117.
  84. Reichenspurner H, Schillinger W, Baldus S, Hausleiter J, Butter C, Schäefer U, Pedrazzini G, Maisano F; ACCESS-EU Phase I Investigators. „Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial.“ Eur J Cardiothorac Surg. 2013 Oct;44(4):e280-8
  85. Röhrig N, Strobl R, Müller M, Perz S, Kääb S, Martens E, Peters A, Linkohr B, Grill E. Directed acyclic graphs helped to identify confounding in the association of disability and electrocardiographic findings: results from the KORA-Age study. J Clin Epidemiol. 2013 Nov 1. pii: S0895-4356(13)00350-8. doi: 10.1016/j.jclinepi.2013.08.012. [Epub ahead of print]
  86. Sarafoff N, Schuster T, Vochem R, Fichtner S, Martinoff S, Schwaiger M, Schömig A, Ibrahim T. Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imaging. J Electrocardiol. 2013 Mar-Apr;46(2):100-6. IF 1.09.
  87. Sarafoff N, Martischnig A, Wealer J, Mayer K, Mehilli J, Sibbing D, Kastrati A. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. J Am Coll Cardiol. 2013 May 21;61(20):2060-6. doi: 10.1016/j.jacc.2013.02.036.Epub 2013 Mar 21. IF  14.09.
  88. Saraffof N, Hausleiter J. Triple-Therapie bei Koronarinterventionen und Indikation zur oralen Antikoagulation. Kardio up 2013; 09(03): 160-164.
  89. Schramm R, Mair H, Becker C, Schwarz F, Bombien R, Juchem G, Sodian R, Kupatt C, Schmitz C. Partial inferior sternotomy and deep hypothermic circulatory arrest for rescue of a failed TAVI case: what does constitute 'inoperable'? Thorac Cardiovasc Surg 2013; 61: 431-4.
  90. Schuetz GM, Schlattmann P, Achenbach S, Budoff M, Garcia MJ, Roehle R, Pontone G, Meijboom WB, Andreini D, Alkadhi H, Honoris L, Bettencourt N, Hausleiter J, Leschka S, Gerber BL, Meijs MF, Shabestari AA, Sato A, Zimmermann E, Schoepf UJ, Diederichsen A, Halon DA, Mendoza-Rodriguez V, Hamdan A, Nørgaard BL, Brodoefel H, Ovrehus KA, Jenkins SM, Halvorsen BA, Rixe J, Sheikh M, Langer C, Martuscelli E, Romagnoli A, Scholte AJ, Marcus RP, Ulimoen GR, Nieman K, Mickley H, Nikolaou K, Tardif JC, Johnson TR, Muraglia S, Chow BJ, Maintz D, Laule M, Dewey M. „Individual patient data meta-analysis for the clinical assessment of coronary computed tomography angiography: protocol of the Collaborative Meta-Analysis of Cardiac CT (CoMe-CCT).“ Syst Rev. 2013 Feb 15;2:13.
  91. Schukro C, Leitner L, Siebermair J, Pezawas T, Stix G, Kastner J, Schmidinger H. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy. Int J Cardiol. 2013 Sep 10;167(6):3006-10.
  92. Schulz C, Engelmann B, Massberg S. Crossroads of coagulation and innate immunity: the case of deep vein thrombosis. J Thromb Haemost. 2013 Jun;11 Suppl 1:233-41. doi: 10.1111/jth.12261. IF 6.08.
  93. Schulz S, Kastrati A, Ferenc M, Massberg S, Birkmeier KA, Laugwitz KL, Kufner S, Gick M, Dommasch M, Schühlen H, Schömig A, Berger PB, Mehilli J, Neumann FJ; Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 4 Trial Investigators. One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial. EuroIntervention. 2013 Aug 22;9(4):430-6. doi: 10.4244/EIJV9I4A71.
  94. Schulz S, Kastrati A, Ferenc M, Massberg S, Birkmeier KA, Laugwitz KL, Kufner S, Gick M, Dommasch M, Schuhlen H, Schomig A, Berger PB, Mehilli J, Neumann FJ. One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-st-segment elevation myocardial infarction: Updated results from the isar-react 4 trial. EuroIntervention. 2013;9:430-436.
  95. Schwarz F, Hinkel R, Baloch E, Marcus RP, Hildebrandt K, Sandner TA, Kupatt C, Hoffmann V, Wintersperger BJ, Reiser MF, Theisen D, Nikolaou K, Bamberg F. Myocardial CT Perfusion Imaging in a Large Animal Model: Comparison of Dynamic Versus Single-Phase Acquisitions. JACC Cardiovasc Imaging 2013 (epub ahead of print).
  96. Schwarz F, Schwab F, Beckmann BM, Schuessler F, Zinsser D, Gölz T, Kääb S, Reiser MF, Theisen D. [Magnetic resonance imaging of hypertrophic cardiomyopathy : evaluation of diastolic function]. Radiologe. 2013 Jan;53(1):15-23. doi: 10.1007/s00117-012-2381-5. German.
  97. Serebruany VL, Aradi D, Kim MH, Sibbing D. Cangrelor infusion is associated with an increased risk for bleeding: Meta-analysis of randomized trials. Int J Cardiol. 2013 Nov 5;169(3):225-8. doi: 10.1016/j.ijcard.2013.08.133. Epub 2013 Sep 7. IF 5.51.
  98. Serebruany VL, Sibbing D, Dinicolantonio JJ. Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond. Cardiology. 2014;127(1):20-4. doi: 10.1159/000354876. Epub 2013 Oct 26.
  99. Sibbing D, Gross L, Orban M, Massberg S. Bleeding and thrombosis risk matters: how long can we stick to the one-size-fits-all strategy of platelet inhibition? JACC Cardiovasc Interv. 2013 Aug;6(8):864-6. doi: 10.1016/j.jcin.2013.06.002.  IF  6.55.
  100. Sibbing D, Orban M, Massberg S. Potent P2Y12 receptor inhibitors in patients with acute coronary syndrome. Agents, indications, issues to consider in clinical practice. Hamostaseologie. 2013;33(1):9-15. doi: 10.5482/HAMO-12-12-0022. Epub 2013 Jan 8. Review. IF 1.48.
  101. Sonne C, Bott-Flugel L, Hauck S, Hadamitzky M, Lesevic H, Demetz G, Braun D, Wolf P, Hausleiter J, Schömig A, Kolb C. Three-Dimensional Echocardiographic Optimization Improves Outcome in Cardiac Resynchronization Therapy Compared to ECG Optimization: A Randomized Comparison.
    Pacing Clin Electrophysiol. 2013 Oct 25. doi: 10.1111/pace.12281. [Epub ahead of print]
  102. Stachel G, Trenkwalder T, Götz F, El Aouni C, Muenchmeier N, Pfosser A, Nussbaum C, Sperandio M, Hatzopoulos AK, Hinkel R, Jon Nelson P, Kupatt C, SDF-1 Fused to a Fractalkine Stalk and a Gpi Anchor Enables functional neovascularization, Stem Cells 2013; 31: 1795:805. IF 7.7.
  103. Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Brühl ML, Gärtner F, Khandoga AG, Legate KR, Pless R, Hepper I, Lauber K, Walzog B, Massberg S. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs. Nat Immunol. 2013 Jan;14(1):41-51. doi: 10.1038/ni.2477. Epub 2012 Nov 25. IF 26.20.
  104. Steinke K, Sachse F, Ettischer N, Strutz-Seebohm N, Henrion U, Rohrbeck M, Klosowski R, Wolters D, Brunner S, Franz WM, Pott L, Munoz C, Kandolf R, Schulze-Bahr E, Lang F, Klingel K, Seebohm G. Coxsackievirus B3 modulates cardiac ion channels. FASEB J 2013 Oct;27(10):4108-21.
  105. Straub N, Beivers A, Lenk E, Aradi D, Sibbing D. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients. Thromb Haemost. 2013 Oct 24;111(2). [Epub ahead of print] IF 6.08.
  106. Tada T, Byrne RA, Cassese S, King L, Schulz S, Mehilli J, Schomig A, Kastrati A. Comparative efficacy of 2 zotarolimus-eluting stent generations: Resolute versus endeavor stents in patients with coronary artery disease. Am Heart J. 2013;165:80-86.
  107. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA; Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013 Dec 17;62(24):2261-73. doi: 10.1016/j.jacc.2013.07.101. Epub 2013 Sep 27.
  108. Theiss HD*, Gross L*, Vallaster M, David R, Brunner S, Brenner C, Nathan P, Assmann G, Mueller-Hoecker J, Vogeser M, Steinbeck G, Franz WM. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. Int J Cardiol. 2013 Oct 9;168(4):3359-69. doi: 10.1016/j.ijcard.2013.04.121. Epub 2013 May 11. IF 5.51.
  109. Theiss HD*, Greif M*, Steinbeck G, Kupatt C, Franz WM. Balloon valvuloplasty for treatment of cardiogenic shock in the era of surgical valve replacement and TAVI. Intern Emerg Med. 2013 Jul 4. [Epub ahead of print] IF 2.34.
  110. Theiss HD, Grabmaier U, Kreissl N, Hagl C, Steinbeck G, Sodian R, Franz WM and Kaczmarek I. Preconditioning with levosimendan before implantation of left ventricular assist devices (LVADs). Artif Organs. 2013 Oct 22. IF 1.964.
  111. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G; on behalf of the Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. „Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.“ Lancet. 2013 Sep 2.
  112. Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. JACC Cardiovasc Interv. 2013.
  113. Todica A*, Brunner S*, Böning G, Lehner S, Nekolla SG, Wildgruber M, Ubleis C, Wängler C, Sauter M, Klingel K, Cumming P, Bartenstein P, Schirrmacher R, Franz WM, Hacker M. [(68)Ga]-Albumin-PET in the Monitoring of Left Ventricular Function in Murine Models of Ischemic and Dilated Cardiomyopathy: Comparison with Cardiac MRI. Mol Imaging Biol 2013 Aug;15(4):441-9. IF 3,10.
  114. Uebleis C, Hellweger S, Laubender RP, Becker A, Sohn HY, Lehner S, Haug A, Bartenstein P, Cumming P, Van Kriekinge SD, Slomka PJ, Hacker M. The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. Int J Cardiovasc Imaging. 2013 Oct;29(7):1645-53. doi: 10.1007/s10554-013-0254-2. Epub 2013 Jun 7.
  115. Uebleis C, Hoyer X, Van Kriekinge SD, Schuessler F, Laubender RP, Becker A, Lehner S, Todica A, Haug A, Bartenstein P, Cumming P, Germano G, Hacker M. Association between left ventricular mechanical dyssynchrony with myocardial perfusion and functional parameters in patients with left bundle branch block. J Nucl Cardiol. 2013 Apr;20(2):253-61. doi: 10.1007/s12350-013-9673-7. Epub 2013 Jan 25.
  116. Wakili R, Clauss S, Schmidt V, Ulbrich M, Hahnefeld A, Schüssler F, Siebermair J, Kääb S, Estner HL. Impact of real-time contact force and impedance measurement in pulmonary vein isolation procedures for treatment of atrial fibrillation. Clin Res Cardiol. 2013 Oct 6. [Epub ahead of print] IF 3.67.
  117. Wang Y, Zhang WY, Hu S, Lan F, Lee AS, Huber B, Lisowski L, Liang P, Huang M, de Almeida PE, Won JH, Sun N, Robbins RC, Kay MA, Urnov FD, Wu JC. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging. Circ Res. 2012 Dec 7;111(12):1494-503.
  118. Wu J, Deisenhofer I, Ammar S, Fichtner S, Reents T, Zhu P, Jilek C, Kolb C, Hess J, Hessling G. Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries. Europace. 2013 Jun;15(6):886-91
  119. Zhang L, Lukowski R, Gaertner F, Lorenz M, Legate KR, Domes K, Angermeier E, Hofmann F, Massberg S. Thrombocytosis as a response to high interleukin-6 levels in cGMP-dependent protein kinase I mutant mice. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1820-8. doi: 10.1161/ATVBAHA.113.301507. Epub 2013 Jun 20. IF 6.34.
  120. Zhang L, Urtz N, Gaertner F, Legate KR, Petzold T, Lorenz M, Mazharian A, Watson SP, Massberg S. Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). Blood. 2013 Aug 1;122(5):791-802. doi: 10.1182/blood-2012-12-473884. Epub 2013 Jun 17. IF 9.06.
  121. von Ziegler F, Schenzle J, Schiessl S, Greif M, Helbig S, Tittus J, Becker C, Becker A. Use of multi-slice computed tomography in patients with chest-pain submitted to the emergency department.  Int J Cardiovasc Imaging. 2013 Sep 13. [Epub ahead of print] IF 2.65.
  122. von Ziegler F, Brendel M, Uebleis C, Helbig S, Greif M, Ruemmler J, Becker C, Hacker M, Steinbeck G, Becker A. SPECT myocardial perfusion imaging as an adjunct to coronary calcium score for the detection of hemodynamically significant coronary artery stenosis. BMC Cardiovasc Disord. 2012 Dec 4;12:116. doi: 10.1186/1471-2261-12-116. IF 1,46.
  123. von Ziegler F, Helbig S, Kreissl N, Meiser B, Becker A, Kaczmarek I. Norepinephrine versus dopamine pretreatment of potential heart donors - impact on long-term outcome. Ann Transplant. 2013 Jun 24;18:320-6. doi: 10.12659/AOT.883960. IF 0,82.
  124. Ziegler T, Horstkotte J, Schwab C, Pfetsch V, Weinmann K, Dietzel S, Rohwedder I, Hinkel R, Gross L, Lee S, Hu J, Soehnlein O, Franz WM, Sperandio M, Pohl U, Thomas M, Weber C, Augustin HG, Fässler R, Deutsch U, Kupatt C. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest. 2013 Jul 1. pii: 66549. doi: 10.1172/JCI66549.  IF 13,1.

 

 

 
 

Campus Großhadern

24h-Notfallnummer
+49 89 4400-75227

Stationäre Aufnahme\
Patientenmanagement

Normalstationen
+49 89 4400-73061

Privatstationen
+49 89 4400-72368


Kardiologische Ambulanz
+49 89 4400-73061

Kardiologische Intensivstation
+49 89 4400-75226

Chest Pain Unit
+49 89 4400-72302

Rhythmologische Hotline
+49 89 4400-73102

Zentrale Notaufnahme
+49 89 4400-73490

Campus Innenstadt

24h-Notfallnummer
+49 89 4400-55001

Stationäre Aufnahme\
Patientenmanagement

Kardiologische Station M2a\
Herzkatheter
+49 89 4400-52316


Kardiologische Ambulanz
+49 89 4400-52305
+49 89 4400-52385

Herzinfarkt_Netzwerk